Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SCHWARTZ, Peter E")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 41

  • Page / 2
Export

Selection :

  • and

Neoadjuvant chemotherapy for the management of ovarian cancerSCHWARTZ, Peter E.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2002, Vol 16, Num 4, pp 585-596, issn 1521-6934, 12 p.Article

Neoadjuvant chemotherapy for advanced ovarian cancer: the role of cytology in pretreatment diagnosisSCHWARTZ, Peter E; WENXIN ZHENG.Gynecologic oncology (Print). 2003, Vol 90, Num 3, pp 644-650, issn 0090-8258, 7 p.Article

Cancer screening in a high risk population: A clinical trialTAYLOR, Kenneth J. W; SCHWARTZ, Peter E.Ultrasound in medicine & biology. 2001, Vol 27, Num 4, pp 461-466, issn 0301-5629Article

Nongenetic screening of ovarian malignanciesSCHWARTZ, Peter E.Obstetrics and gynecology clinics of North America. 2001, Vol 28, Num 4, issn 0889-8545, vii, 637-651 [16 p.]Article

Malignant transformation of myomas : Myth or reality?SCHWARTZ, Peter E; KELLY, Michael G.Obstetrics and gynecology clinics of North America. 2006, Vol 33, Num 1, issn 0889-8545, xii-xiii, 183-198 [21 p.]Article

Eradication of Chemotherapy-Resistant CD44+ Human Ovarian Cancer Stem Cells in Mice by Intraperitoneal Administration of Clostridium Perfringens EnterotoxinCASAGRANDE, Francesca; COCCO, Emiliano; RUTHERFORD, Thomas J et al.Cancer. 2011, Vol 117, Num 24, pp 5519-5528, issn 0008-543X, 10 p.Article

Induction of Human Tumor-associated Differentially Expressed Gene-12 (TADG-12/TMPRSS3)-specific Cytotoxic T Lymphocytes in Human Lymphocyte Antigen-A2.1-positive Healthy Donors and Patients With Advanced Ovarian CancerBELLONE, Stefania; ANFOSSI, Simone; O'BRIEN, Timothy J et al.Cancer. 2009, Vol 115, Num 4, pp 800-811, issn 0008-543X, 12 p.Article

Molecular Identification of Latent Precancers for Endometrial Serous Carcinoma in Benign-Appearing EndometriumXI ZHANG; LIANG, Sharon X; LIN JIA et al.The American journal of pathology. 2009, Vol 174, Num 6, pp 2000-2006, issn 0002-9440, 7 p.Article

Cytohistologic correlation rates between conventional papanicolaou smears and ThinPrep cervical cytology: A comparisonCHACHO, Mary S; MATTIE, Mark E; SCHWARTZ, Peter E et al.Cancer. 2003, Vol 99, Num 3, pp 135-140, issn 0008-543X, 6 p.Article

Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervixLACEY, James V; SWANSON, Christine A; SCHWARTZ, Peter E et al.Cancer. 2003, Vol 98, Num 4, pp 814-821, issn 0008-543X, 8 p.Article

HER2/neu as a Potential Target for Immunotherapy in Gynecologic CarcinosarcomasGUZZO, Federica; BELLONE, Stefania; SCHWARTZ, Peter E et al.International journal of gynecological pathology. 2012, Vol 31, Num 3, pp 211-221, issn 0277-1691, 11 p.Article

Outcomes of small bowel obstruction in patients with previous gynecologic malignanciesMIRENSKY, Tamar L; SCHUSTER, Kevin M; ALI, Unzila A et al.The American journal of surgery. 2012, Vol 203, Num 4, pp 472-479, issn 0002-9610, 8 p.Article

Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovaryTANGIR, Jacob; ZELTERMAN, Daniel; WENGING MA et al.Obstetrics and gynecology (New York. 1953). 2003, Vol 101, Num 2, pp 251-257, issn 0029-7844, 7 p.Article

Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failureYALCIN, Omer T; RUTHERFORD, Thomas J; CHAMBERS, Setsuko K et al.European journal of obstetrics, gynecology, and reproductive biology. 2003, Vol 106, Num 1, pp 64-68, issn 0301-2115, 5 p.Article

Epithelial ovarian cancer cells secrete functional fas ligandABRAHAMS, Vikki M; STRASZEWSKI, Shawn L; KAMSTEEG, Marijke et al.Cancer research (Baltimore). 2003, Vol 63, Num 17, pp 5573-5581, issn 0008-5472, 9 p.Article

Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or youngerLIANG, Sharon X; PEARL, Micheal; WENXIN ZHENG et al.International journal of cancer (Print). 2011, Vol 128, Num 4, pp 763-770, issn 0020-7136, 8 p.Article

Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibodyVARUGHESE, Joyce; COCCO, Emiliano; SANTIN, Alessandro D et al.American journal of obstetrics and gynecology. 2011, Vol 205, Num 6, pp 567-568, issn 0002-9378, 2 p.Article

Sexuality and intimacy after gynecological cancerRATNER, Elena S; FORAN, Kelly A; SCHWARTZ, Peter E et al.Maturitas (Amsterdam). 2010, Vol 66, Num 1, pp 23-26, issn 0378-5122, 4 p.Article

Diagnostic Markers for Early Detection of Ovarian CancerVISINTIN, Irene; ZIDING FENG; AZORI, Masoud et al.Clinical cancer research. 2008, Vol 14, Num 4, pp 1065-1072, issn 1078-0432, 8 p.Article

The Oncofetal Protein IMP3 : A Novel Biomarker for Endometrial Serous CarcinomaWENXIN ZHENG; XIAOFANG YI; FADARE, Oluwole et al.The American journal of surgical pathology. 2008, Vol 32, Num 2, pp 304-315, issn 0147-5185, 12 p.Article

The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. DiscussionFISHMAN, David A; COHEN, Leeber; BLANK, Stephanie V et al.American journal of obstetrics and gynecology. 2005, Vol 192, Num 4, pp 1214-1222, issn 0002-9378, 9 p.Conference Paper

Tubulin-β-III Overexpression by Uterine Serous Carcinomas Is a Marker for Poor Overall Survival After Platinum/Taxane Chemotherapy and Sensitivity to EpothilonesROQUE, Dana M; BELLONE, Stefania; RUTHERFORD, Thomas J et al.Cancer. 2013, Vol 119, Num 14, pp 2582-2592, issn 0008-543X, 11 p.Article

Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitroCROSS, Sarah N; COCCO, Emiliano; BELLONE, Stefania et al.American journal of obstetrics and gynecology. 2010, Vol 203, Num 2, pp 162-164, issn 0002-9378, 3 p.Article

Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic VaccinesBELLONE, Stefania; EL-SAHWI, Karim; SCHWARTZ, Peter E et al.Journal of virology. 2009, Vol 83, Num 13, pp 6779-6789, issn 0022-538X, 11 p.Article

Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United StatesALTEKRUSE, Sean F; LACEY, James V; SCHWARTZ, Peter E et al.American journal of obstetrics and gynecology. 2003, Vol 188, Num 3, pp 657-663, issn 0002-9378, 7 p.Article

  • Page / 2